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Abstract
Nowadays, a whole range of genetherapeutic methods is being used to restore a lost protein
function due to mutation, a big number of preclinical and clinical studies of potential drugs that
may allow to implement an etiotropic approach is being performed. One of the most prevalent
and socially  significant  groups of  genetic  pathologies is  musculardystrophy,  including such
diseases  as  Duchenne  muscular  dystrophy  and  dysfelinopathy.  Despite  a  large  number
ofstudies in this field, there is no effective method of gene therapy for these diseases yet. This
work  is  intended  to  review  main  genetherapeutic  methods  in  myodystrophy  treatment,
especially  pre-  and  posttranscriptional  genetic  (biosynthetic)  information  modification,  and
analyze most optimal of them.
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